Ignite Creation Date:
2024-10-25 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06512181
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-16
Brief Title:
Uterine Preservation in the Management of Placenta Accreta Spectrum Disorders
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Uterine Preservation in the Management of Placenta Accreta Spectrum Disorders
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
U-PRESERVE
Brief Summary:
This study for the conservative management of placenta accreta spectrum disorders PAS which are a major cause of maternal morbidity and mortality The most common management strategy for PAS in the United States is a preterm cesarean-hysterectomy However accumulating data show that conservative management is safer and is preferred by some patients In selected participants n15 who desire uterine preservation the investigators provide the option of conservative management which will be defined as leaving the placenta in the uterus after delivery of the infant This is a single-arm single-site pilot study where all participants will be carefully monitored during a standard postpartum inpatient stay and with outpatient follow-up until the uterus is empty
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None